<p>Crude and adjusted pandemic H1N1 vaccine effectiveness per age category: Primary analysis with baseline at 30-11-2009 & Post hoc Time Dependent Analysis with baseline at 01-10-2009.</p
<p>Each scenario increments on a baseline strategy (numbers refer to Table S7 in <a href="http://www...
<p>Proportion of pandemic (H1N1) 2009 monovalent vaccine doses administered, by age group and type o...
An analysis was undertaken to measure age-specific vaccine effectiveness (VE) of 2010/11 trivalent s...
*<p>adjusted for number of different drugs prescribed and number of GP contacts in year before.</p
<p>OR – odds ratio; 95% CI –95% confidence interval.</p>*<p>Unadjusted.</p>**<p>Adjusted for sex, ag...
<p>Profile likelihood method was used for estimating the 95% confidence intervals (95%CI) for the va...
<p>*In these analyses, individuals vaccinated before the identified time duration considered unvacci...
<p><sup>a</sup>. VE (vaccine effectiveness) adjusted for month of illness, sex, age group</p><p>Vacc...
<p>A, Proportion of seropositive versus-negative subjects by birth decades. B, Cumulative geometric ...
<p>BC = British Columbia, AB = Alberta, MB = Manitoba, ON = Ontario, QC = Québec; d = days; NE = not...
In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in pri...
*<p>Adjusted for sex, age group, and number of prior vaccinations.</p><p>̂Adjusted for sex, age grou...
<p>Adjusted influenza vaccine effectiveness (IVE) assessed for all ages, <65 and> = 65, and by: a) v...
<p><b>Note.</b> IVE = influenza vaccine effectiveness; CI = confidence interval; Hosp = hospitalizat...
<p>Dashed line represents estimated vaccine effectiveness in all patients in primary analysis. All e...
<p>Each scenario increments on a baseline strategy (numbers refer to Table S7 in <a href="http://www...
<p>Proportion of pandemic (H1N1) 2009 monovalent vaccine doses administered, by age group and type o...
An analysis was undertaken to measure age-specific vaccine effectiveness (VE) of 2010/11 trivalent s...
*<p>adjusted for number of different drugs prescribed and number of GP contacts in year before.</p
<p>OR – odds ratio; 95% CI –95% confidence interval.</p>*<p>Unadjusted.</p>**<p>Adjusted for sex, ag...
<p>Profile likelihood method was used for estimating the 95% confidence intervals (95%CI) for the va...
<p>*In these analyses, individuals vaccinated before the identified time duration considered unvacci...
<p><sup>a</sup>. VE (vaccine effectiveness) adjusted for month of illness, sex, age group</p><p>Vacc...
<p>A, Proportion of seropositive versus-negative subjects by birth decades. B, Cumulative geometric ...
<p>BC = British Columbia, AB = Alberta, MB = Manitoba, ON = Ontario, QC = Québec; d = days; NE = not...
In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in pri...
*<p>Adjusted for sex, age group, and number of prior vaccinations.</p><p>̂Adjusted for sex, age grou...
<p>Adjusted influenza vaccine effectiveness (IVE) assessed for all ages, <65 and> = 65, and by: a) v...
<p><b>Note.</b> IVE = influenza vaccine effectiveness; CI = confidence interval; Hosp = hospitalizat...
<p>Dashed line represents estimated vaccine effectiveness in all patients in primary analysis. All e...
<p>Each scenario increments on a baseline strategy (numbers refer to Table S7 in <a href="http://www...
<p>Proportion of pandemic (H1N1) 2009 monovalent vaccine doses administered, by age group and type o...
An analysis was undertaken to measure age-specific vaccine effectiveness (VE) of 2010/11 trivalent s...